Similar Search Results

Tracing the Linkages Between Scientific Research and Energy Innovations : A Comparison of Clean and Dirty Technologies

Perrons, Robert K. - 2020

development of new energy technologies (Popp, 2017). Energy innovation tends to consist of a series of partially overlapping …

Persistent link: https://www.econbiz.de/10012481080

Expected Profits and The Scientific Novelty of Innovation

Dranove, David - 2020

Innovation policy involves trading off monopoly output and pricing in the short run in exchange for incentives for …

Persistent link: https://www.econbiz.de/10012481677

The Impact of Regulation on Innovation

Aghion, Philippe; Bergeaud, Antonin; Van Reenen, John - National Bureau of Economic Research - 2021

Does regulation affect the pace and nature of innovation and if so, by how much? We build a tractable and quantifiable … sharp reduction in the firm's innovation response to exogenous demand shocks for firms just below the regulatory threshold …. We then quantitatively fit the parameters of the model to the data, finding that innovation at the macro level is about 5 …

Persistent link: https://www.econbiz.de/10012482599

Innovation, Diffusion, and Trade

Eaton, Jonathan - 2006

We explore the determinants of research specialization across countries and its consequences for relative wages. Using a dynamic Ricardian model we examine the effects of faster international technology diffusion and lower trade barriers on the incentive to innovate. In the absence of any...

Persistent link: https://www.econbiz.de/10012466280

The Role of Assets In Place : Loss of Market Exclusivity and Investment

Higgins, Matthew J. - 2020

We utilize a novel identification strategy to analyze the impact of assets in place on firms' decisions for future projects. We exploit the context in the pharmaceutical industry, where the loss of market exclusivity for a branded drug can be used to separate the impact of cash flows generated...

Persistent link: https://www.econbiz.de/10012481442

Private and Social Returns to R&D : Drug Development and Demographics

Benmelech, Efraim; Eberly, Janice C.; Krieger, Joshua L.; … - National Bureau of Economic Research - 2021

Investment in intangible capital--in particular, research and development--increased dramatically since the 1990s. However, productivity growth remains sluggish in recent years. One potential reason is that a significant share of the increase in intangible investment is geared toward consumer...

Persistent link: https://www.econbiz.de/10012482573

The Diffusion of Scientific Knowledge Across Time and Space : Evidence from Professional Transitions for the Superstars of Medicine

Azoulay, Pierre - 2011

Are scientific knowledge flows embodied in individuals, or "in the air"? To answer this question, we measure the effect of labor mobility in a sample of 9,483 elite academic life scientists on the citation trajectories associated with individual articles (resp. patents) published (resp. granted)...

Persistent link: https://www.econbiz.de/10012461974

International R&D Spillovers and Institutions

Coe, David T. - 2008

The empirical analysis in "International R&D Spillovers" (Coe and Helpman, 1995) is first revisited by applying modern panel cointegration estimation techniques to an expanded data set that we have constructed for the purpose of this study. The new estimates confirm the key results reported in...

Persistent link: https://www.econbiz.de/10012464577

University Patenting : Estimating the Diminishing Breadth of Knowledge Diffusion and Consumption

Rosell, Carlos - 2006

The rate of university patenting increased dramatically during the 1980s. To what extent did the knowledge flow patterns associated with public sector inventions change as university administrators and faculty seemingly became more commercially oriented? Using a Herfindahl-type measure of patent...

Persistent link: https://www.econbiz.de/10012466021

The Future of Drug Development : The Economics of Pharmacogenomics

Vernon, John A. - 2005

This paper models how the evolving field of pharmacogenomics (PG), which is the science of using genomic markers to predict drug response, may impact drug development times, attrition rates, costs, and the future returns to research and development (R&D). While there still remains an abundance...

Persistent link: https://www.econbiz.de/10012466796

1
2
3
4
5
6
7
8
Next
Last